As pipelines diversify and new conjugation approaches emerge, facilities designed around today’s processes must be prepared ...

The distinctive properties of USP's mAb reference standards show utility for qualifying and monitoring methods for thermal ...

NIBRT and San Jacinto College's biotech center in Houston train students for in-demand biomanufacturing and cell and gene therapy careers.

During our conversation, Seyf discussed his company’s involvement in the Australian ecosystem and how Australia is expanding ...

Connecting existing downstream steps delivers the value of continuous bioprocessing, says executive Jon Coffman at BioProcess ...

Ultimately, the discussion suggested that progress will come not from replacing CHO wholesale, but from pairing earlier, ...

The physics that dictate this field’s timelines remain unforgiving. Radiopharmaceuticals cannot be inventoried the way ...

Reformatting historical data and getting scientists to agree on how to generate it are among the biggest hurdles in hybrid ...

Autolomous CEO Alexander Seyf explains why collaboration, not competition, could unlock progress in cell and gene therapy ...

Biopharmaceutical manufacturing depends on complex biological and separation processes that must operate consistently under strict quality expectations. Upstream operations such as seed train ...

Earlier this week, biotechnology company Amplitude Therapeutics announced a partnership with global pharmaceutical conglomerate Eli Lilly. The agreement will focus on researching a trans-amplifying ...

Industrial manufacturing of recombinant therapeutic proteins using Chinese hamster ovary (CHO) cells is a process dominated by multiple levels of selection, such as selection of the right therapeutic ...